BeStock  
Stocks › Biotechnology › TRVI

Trevi Therapeutics TRVI

US equityMarket cap rank #2802Biotechnology
$13.72 −$0.19 (-1.37%)
Pre-market · Oct 6, 4:10 am ET · After hours $13.72 0.00%
Open$13.97
Prev close$13.91
Day range$13.51 – $14.11
Volume1.72M
Market cap$1.95B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership106.2%-1.26 pts vs. prior quarter
Institutions holding252+2 vs. prior quarter
Insider trades (recent)38 buys / 12 sellsNet buying
Short interest8.47% of floatDays to cover 8.8 · as of 15 Sep 2026
Short-sale volume share26.1%5-day average of daily volume

Short-sale volume as % of daily volume

17%22%27%31%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$4.51M (11 inflow days, 9 outflow days).

The five largest holders on file together own 37.4% of shares outstanding.

Largest holders

  • New Enterprise Associates, Inc.9.28%
  • FMR8.82%
  • BlackRock7.83%
  • Frazier Life Sciences Management, LP6.98%
  • Vanguard Capital Management, LLC4.47%
  • Wellington Management Group3.99%
  • Vivo Capital, LLC3.58%
  • Woodline Partners LP2.86%

By investor type

  • Mutual Fund51.57%
  • VC/PE Fund29.77%
  • Hedge Fund18.94%
  • Public Company4.52%
  • Private Company0.87%
  • Individual/Insider0.70%
  • Government Pension Fund0.28%
  • Family Office/Trust0.18%

Reported short interest has fallen from 9.77% to 8.47% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 12,070,625 8.5% 8.8
31 Aug 2026 12,012,371 8.4% 8.0
14 Aug 2026 12,657,630 8.9% 7.8
31 Jul 2026 13,147,012 9.3% 5.4
15 Jul 2026 12,653,483 8.9% 4.8
30 Jun 2026 13,870,118 9.8% 4.0

Discussion

No comments yet — be the first to weigh in on TRVI.

Leave a comment

Scroll to Top